01 3Tracleer
02 1Tracleer/ bosentan
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 1,010
2015 Revenue in Millions : 1,200
Growth (%) : -16
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 403
2016 Revenue in Millions : 1,078
Growth (%) : -63
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 546
2017 Revenue in Millions : 403
Growth (%) : 35%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 341
2018 Revenue in Millions : 546
Growth (%) : -38
LOOKING FOR A SUPPLIER?